Evidence map›Paper›PMID 38661296›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2024

The impact of macro- and micro-steatosis on the outcomes of patients who undergo liver transplant: Analysis of the UNOS-STAR database.

David Uihwan Lee, Ashley Yoo, Sindhura Kolachana, Jaehyun Lee, Reid Ponder, Gregory Hongyuan Fan, Ki Jung Lee, KeeSeok Lee, Kimmy Schuster, Harrison Chou and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

David Uihwan LeeDepartment of Medicine, Division of Gastroenterology and Hepatology, Liver Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ashley YooDepartment of Medicine, Division of Gastroenterology and Hepatology, Liver Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Sindhura KolachanaDepartment of Medicine, Division of Gastroenterology and Hepatology, Liver Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Jaehyun LeeDepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
Reid PonderDepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-3240-1576
Gregory Hongyuan FanDepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
Ki Jung LeeDepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
KeeSeok LeeDepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
Kimmy SchusterDepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-2352-438X
Harrison ChouDepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
Hannah ChouDepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
Catherine SunDepartment of Medicine, Division of Gastroenterology and Hepatology, Liver Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Michael ChangDepartment of Medicine, Division of Gastroenterology and Hepatology, Liver Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-3207-746X
Alex PuDepartment of Medicine, Division of Gastroenterology and Hepatology, Liver Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-7829-9845
Nathalie Helen UrrunagaDepartment of Medicine, Division of Gastroenterology and Hepatology, Liver Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Tufts University · USUniversity of Maryland, Baltimore · US

Funding

Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
NIDDK NIH HHS T32 DK067872
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe presence of steatosis in a donor liver and its relation to post-transplantation outcomes are not well defined. This study evaluates the effect of the presence and severity of micro- and macro-steatosis of a donor graft on post-transplantation outcomes.

methodsThe UNOS-STAR registry (2005-2019) was used to select patients who received a liver transplant graft with hepatic steatosis. The study cohort was stratified by the presence of macro- or micro-vesicular steatosis, and further stratified by histologic grade of steatosis. The primary endpoints of all-cause mortality and graft failure were compared using sequential Cox regression analysis. Analysis of specific causes of mortality was further performed.

resultsThere were 9184 with no macro-steatosis (control), 150 with grade 3 macro-steatosis, 822 with grade 2 macro-steatosis and 12 585 with grade 1 macro-steatosis. There were 10 320 without micro-steatosis (control), 478 with grade 3 micro-steatosis, 1539 with grade 2 micro-steatosis and 10 404 with grade 1 micro-steatosis. There was no significant difference in all-cause mortality or graft failure among recipients who received a donor organ with any evidence of macro- or micro-steatosis, compared to those receiving non-steatotic grafts. There was increased mortality due to cardiac arrest among recipients of a grade 2 macro-steatosis donor organ.

conclusionThis study shows no significant difference in all-cause mortality or graft failure among recipients who received a donor liver with any degree of micro- or macro-steatosis. Further analysis identified increased mortality due to specific aetiologies among recipients receiving donor organs with varying grades of macro- and micro-steatosis.

Indexed as

Fatty LiverLiver TransplantationRegistriesAdultAgedDatabases, FactualFemaleGraft SurvivalHumansMaleMiddle AgedSeverity of Illness IndexTissue DonorsTreatment Outcomemacro‐steatosismicro‐steatosispost‐liver transplant outcomesprognosticationUNOS‐STAR registry

Identifiers

PMID38661296
PMCPMC11386057
OpenAlexW4395465184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.